Post Profile






Combination Strategy Could Hold Promise for Ovarian Cancer

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.
read more

share

Related Posts


Animal Study Shows Experimental Drug Combined with Standard Chemo May Shrink Treatment-Resistant Ovarian Cancers

Health : Newswise Medical News

Working in cell cultures and mice, researchers at Johns Hopkins have found that an experimental drug called fostamatinib combined with the chemotherapy drug paclitaxel may overcome ovarian cancer cells' resistance to paclitaxel.

Tumor Cells In Mice Destroyed By Drug From Mediterranean Weed

Health : Medical News Today

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel - undetected by normal cells - through the bloodstream until activated by specific canc...

Dual Strategy Teaches Mouse Immune Cells to Overcome Cancer's Evasive Techniques

Health : Newswise Medical News

By combining two treatment strategies, both aimed at boosting the immune system's killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. And...

Human Tumor 'Avatars' Reveal New Genetic Sources of Drug Response in Late-Stage Colorectal Cancer Therapy

Health : Newswise Medical News

Using pieces of human tumors grafted into mice, a team led by Johns Hopkins Kimmel Cancer Center researchers and their colleagues from the University of Torino has identified new mutations in six genes related to drug resistance and...

Combination strategy could hold promise for ovarian cancer

Diseases & Conditions / Cancer : ScienceDaily: Cancer

Mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any o...

Comments


Copyright © 2016 Regator, LLC